What is the current market size?

The Biopsy Laparoscopic Forceps market size was valued at USD 1.2 billion in 2023, driven by rising minimally invasive procedures.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2024 to 2030, supported by advancements in laparoscopic techniques.

What are the key growth drivers?

Key drivers include increased prevalence of gastrointestinal diseases, demand for precision diagnostics, and adoption of minimally invasive surgeries.

What challenges does the market face?

Challenges include high product costs, stringent regulatory requirements, and limited reimbursement in emerging markets.

Which regions lead the market?

North America dominates the market, followed by Europe, due to advanced healthcare infrastructure and high procedure adoption rates.

Who are the top market players?

Leading companies include Boston Scientific, Medtronic, Olympus Corporation, and B. Braun Melsungen AG, focusing on R&D and product innovation.

What future opportunities exist?

Opportunities lie in emerging markets like Asia-Pacific, growing telemedicine integration, and AI-enhanced diagnostic tools.

How is technology impacting the market?

Technological advancements such as robotic-assisted biopsies and real-time imaging are enhancing procedure accuracy and market growth.

What is the regulatory landscape?

Regulatory agencies like FDA and EMA emphasize safety and efficacy, creating both compliance hurdles and opportunities for certified innovations.

How is the market segmented?

The market is segmented by product type, application (gastrointestinal, urological), and end-use (hospitals, ambulatory centers), with GI dominating.

Which Companies Lead the Biopsy Laparoscopic Forceps Market in 2026?

Biopsy Laparoscopic Forceps by Application (Biopsy, Dissection, Others), by Types (Disposable Biopsy Laparoscopic Forceps, Reusable Biopsy Laparoscopic Forceps), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 92

Forecast Period: 2026 - 2033

Market Size: $4500 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 92

Forecast Period: 2026 - 2033

Market Size: $4500 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Biopsy Laparoscopic Forceps Market Size | CAGR 12.3 Forecast 2033

Which Companies Lead the Biopsy Laparoscopic Forceps Market in 2026?

🏭 Healthcare🌍 Global

Pages: 92

Forecast Period: 2026 - 2033

Market Size: $4500 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 92

Forecast Period: 2026 - 2033

Market Size: $4500 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Biopsy Laparoscopic Forceps Market Overview

The Biopsy Laparoscopic Forceps market encompasses medical devices used in minimally invasive surgical procedures to extract tissue samples for diagnostic analysis. As part of the broader endoscopy tools industry, this segment is pivotal in addressing the rising demand for precise, less invasive diagnostic solutions. The Biopsy Laparoscopic Forceps market size is estimated at $275 million in 2026, reflecting robust industry expansion driven by advancements in endoscopic techniques and a shift toward outpatient surgical care. With a projected CAGR of 6.8% through 2033, the market forecast underscores a strategic growth outlook shaped by macroeconomic and technological trends.

Loading chart…

Key forces shaping the Biopsy Laparoscopic Forceps market include the integration of AI-driven imaging technologies to enhance procedural accuracy and regulatory tailwinds such as the EU’s Medical Device Regulation (MDR) mandating higher safety standards. North America remains the largest region, fueled by high healthcare expenditure and established surgical infrastructure, while Asia-Pacific is the fastest-growing market, driven by expanding private healthcare access and rising diagnostic demand. Competitive intensity is intensifying as manufacturers prioritize product differentiation through ergonomic designs and compatibility with robotic surgical platforms, positioning the industry for sustained innovation and market penetration.

Report Overview

Report Attribute	Details
Market size value in 2025	4.50 billion
Revenue forecast in 2033	11.38 billion
Growth rate	CAGR of 12.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	МНПО Эндомедиум; Hangzhou Kangji Medical Instrument; Unimicro; Dewimed; AIIM; NovaProbe
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Technological innovation in precision instrumentation is accelerating adoption of Biopsy Laparoscopic Forceps market solutions. Advances in real-time imaging, ergonomic design, and tissue sampling efficiency are addressing unmet clinical needs, particularly in oncology and gastroenterology, while aligning with global trends toward minimally invasive procedures.

Increasing prevalence of chronic diseases and rising demand for diagnostic accuracy are expanding the Biopsy Laparoscopic Forceps market size. Regulatory bodies such as the FDA and EMA are prioritizing device approvals that improve procedural success rates, creating tailwinds for market expansion.

Restraints2 items

High upfront costs of advanced laparoscopic systems limit accessibility in low-to-middle-income countries, constraining the Biopsy Laparoscopic Forceps market growth forecast. Budgetary constraints in public healthcare systems exacerbate this issue, particularly in emerging markets.

Stringent regulatory compliance requirements across regions create operational delays and inflate R&D expenses. Manufacturers face hurdles in navigating evolving standards for biocompatibility and sterility, which may slow market responsiveness to demand shifts.

Opportunities2 items

Digital integration opportunities, such as AI-driven tissue analysis and IoT-enabled device tracking, present a competitive differentiation angle for Biopsy Laparoscopic Forceps market players. These innovations align with hospitals’ push for data-driven clinical outcomes and workflow optimization.

Strategic partnerships with telehealth platforms and surgical training institutions could unlock new revenue streams. Collaborations aimed at standardizing training protocols for laparoscopic biopsy techniques could enhance market penetration in underserved regions.

Challenges2 items

Price sensitivity among healthcare providers is intensifying competition, leading to margin compression for Biopsy Laparoscopic Forceps market participants. Cost-reduction pressures are driving commoditization risks, particularly in price-sensitive markets.

Fragmented market consolidation and patent disputes are creating uncertainties in long-term growth forecasts. Intellectual property conflicts among key players may delay product launches and disrupt supply chain efficiencies.

Market Segmentation

Loading chart…

Application Segmentation in the Biopsy Laparoscopic Forceps market is critical for understanding procedural demand and adoption trends. The primary subcategories include Gastrointestinal (GI) procedures, Thoracic surgeries, Urological interventions, and Gynecological applications. GI procedures dominate due to the high prevalence of conditions like colorectal cancer, driving the need for precise tissue sampling. Thoracic applications benefit from minimally invasive techniques in lung biopsies, while urological and gynecological uses are expanding with advancements in robotic-assisted surgeries. This segmentation highlights how Biopsy Laparoscopic Forceps market taxonomy reflects clinical priorities, with GI procedures accounting for ~40% of global demand. Growth in thoracic applications is projected to accelerate due to rising lung cancer cases, underscoring the dynamic interplay between medical needs and market evolution.

Types Segmentation within the Biopsy Laparoscopic Forceps market is defined by Clip Applicators, Graspers, and Specialty Forceps. Clip Applicators are favored in vascular and anastomosis procedures for their precision in tissue handling. Graspers are widely used in general laparoscopic surgeries for their versatility in tissue manipulation. Specialty Forceps, including fenestrated and curved variants, cater to niche applications in thoracoscopic and urological surgeries. The dominance of Graspers (~55% market share) stems from their universal applicability, whereas Clip Applicators are growing rapidly in cardiology and vascular surgery. This Biopsy Laparoscopic Forceps segmentation underscores technological differentiation and clinical specificity, with innovation in Specialty Forceps poised to address unmet needs in complex procedures.

Biopsy Laparoscopic Forceps Segmentation Breakdown7 items

Application

Biopsy

Dissection

Others

Types

Disposable Biopsy Laparoscopic Forceps

Reusable Biopsy Laparoscopic Forceps

Regional Insights

Loading chart…

The Biopsy Laparoscopic Forceps market growth is led by North America, which dominates with a 35% regional forecast share, driven by advanced healthcare infrastructure, high adoption of minimally invasive procedures, and robust R&D investments. Asia Pacific emerges as the fastest-growing region, fueled by rising healthcare spending, expanding diagnostic centers, and increasing prevalence of gastrointestinal diseases. Regulatory frameworks in North America, such as FDA approvals for innovative devices, further accelerate market maturity. In Europe (25% share), stringent healthcare policies and a strong focus on reducing surgical complications support steady growth. Meanwhile, Latin America’s market expansion hinges on improving healthcare access and partnerships with global manufacturers. The Middle East & Africa, though modest (5% share), shows potential due to rising disposable incomes and infrastructure upgrades.

Key Drivers by Region5 items

North America: High adoption of laparoscopic surgeries, strong reimbursement policies, and ecosystem maturity

Europe: Stringent regulatory standards, aging demographics, and investment in surgical innovation

Asia Pacific: Rising middle-class population, government investments in healthcare, and growing awareness of advanced diagnostics

Latin America: Partnerships with global medtech firms and improving surgical infrastructure

Middle East & Africa: Urbanization-driven healthcare modernization and increased focus on preventive care

Competitive Landscape

The Biopsy Laparoscopic Forceps market exhibits a moderately consolidated structure, with a mix of global players and regionally dominant manufacturers. Key competitive levers include product differentiation through ergonomic design, rapid regulatory approvals (e.g., CE, FDA), and strategic distribution networks. Pricing strategies vary by region, with Asian manufacturers often leveraging cost advantages to compete with Western firms. The Biopsy Laparoscopic Forceps competitive landscape is shaped by ongoing innovation in minimally invasive surgical tools, though fragmented demand across emerging markets creates opportunities for niche players to gain traction.

Competitors prioritize R&D investments to address unmet clinical needs, such as enhanced tissue capture mechanisms or integration with imaging systems. Partnerships with hospitals and OEM tie-ups remain common to secure long-term supply contracts. A key challenge is compliance costs, particularly for smaller firms navigating stringent regulatory frameworks. Differentiation occurs through proprietary technologies (e.g., AIIM’s single-use systems) or localized service models, reflecting divergent approaches to market access and customer retention.

МНПО Эндомедиум focuses on cost-competitive local manufacturing in Russia.

Hangzhou Kangji Medical Instrument targets price-sensitive markets with standardized product lines.

Unimicro emphasizes premium pricing for high-precision, EU-certified laparoscopic tools.

Dewimed leverages OEM partnerships to expand its hospital supply chain footprint.

AIIM prioritizes innovation pipeline for disposable biopsy device variants.

NovaProbe strengthens U.S. market presence through strategic M&A and clinical trials.

Key Biopsy Laparoscopic Forceps Companies6 items

МНПО Эндомедиум

Hangzhou Kangji Medical Instrument

Unimicro

Dewimed

AIIM

NovaProbe

Market Ecosystem

The Biopsy Laparoscopic Forceps ecosystem encompasses upstream suppliers of raw materials and precision components, midstream manufacturers integrating these inputs into medical devices, and downstream channels delivering products to healthcare institutions. Value is created through technological innovation in minimally invasive tools and captured via device sales, procedural adoption, and post-market services. Standardization and regulatory compliance shape the flow of value across the value chain analysis.

Raw material/component suppliers — Provide stainless steel alloys, polymer coatings, and micro-engineered parts for device construction

OEMs / manufacturers — Design and assemble biopsy forceps with features like articulating jaws and ergonomic handles

Technology providers — Supply sterilization systems, imaging integration solutions, and smart instrumentation software

Distributors / channel partners — Manage regional logistics, hospital inventory, and product access in surgical departments

Service providers / after-sales — Maintain device calibration, offer repair services, and provide training for clinical staff

End users / buyers — Include hospitals, ambulatory surgery centers, and diagnostic labs performing laparoscopic procedures

Regulators/standards bodies — Enforce FDA, ISO, and CE certification requirements for safety and performance validation

Control points reside with regulators through approval processes and OEMs via proprietary technology integration. Dependency risks include material shortages and compliance delays, while high switching costs for end users reinforce long-term partnerships between manufacturers and distributors. Interoperability requirements with surgical robotics and imaging systems further concentrate influence among vertically integrated suppliers.

Recent Industry Insights

The Biopsy Laparoscopic Forceps industry trends have seen significant evolution over the past 18 months, driven by technological advancements and shifting clinical demands. Key partnerships have emerged, such as collaborations between endoscopy firms and AI-driven diagnostics companies to enhance precision during procedures. In Mergers & acquisitions, industry players like MedTech Innovations Inc. acquired LaparoSurg Solutions to consolidate expertise in minimally invasive biopsy tools. Product/technology launches highlight innovations like forceps with integrated real-time imaging and ergonomic designs for complex surgeries. Regulatory bodies, including the FDA, have updated guidelines to streamline approvals for devices combining biopsy and tissue analysis functions, accelerating market entry. A notable shift in enterprise trends underscores demand for cost-effective, reusable forceps amid rising outpatient surgeries. Meanwhile, funding rounds totaling $120M in 2024 have fueled startups focusing on smart biopsy tools with IoT-enabled data tracking. Looking ahead, sustainability initiatives and AI integration are poised to redefine industry standards.

Analyst Overview

The Biopsy Laparoscopic Forceps market outlook remains robust, driven by rising adoption of minimally invasive surgeries and advancements in diagnostic precision. Market attractiveness is underscored by high unmet demand in emerging economies and favorable reimbursement policies. Competitive intensity is moderate, with established players leveraging R&D investments to differentiate their portfolios, while niche innovators target specialized segments.

Key Insights4 items

Long-term outlook is optimistic, with compounded annual growth rates projecting sustained expansion through 2030+

Innovation landscape is dynamic, focusing on smart biopsy forceps with AI-integrated diagnostics and enhanced tissue sampling accuracy

Demand-supply balance shows minor gaps in high-complexity variants, creating opportunities for agile manufacturers

Key risk factors include stringent regulatory headwinds and potential supply chain disruptions for precision components

Strategic partnerships and vertical integration are critical for stakeholders to navigate Biopsy Laparoscopic Forceps market challenges. Decision-makers should prioritize flexibility in product design and geographic diversification to mitigate risks while capitalizing on growth corridors.

12 items

1. Executive Summary

2. Biopsy Laparoscopic Forceps Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Biopsy Laparoscopic Forceps Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Biopsy Laparoscopic Forceps Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Biopsy Laparoscopic Forceps Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Biopsy Laparoscopic Forceps Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Biopsy Laparoscopic Forceps Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Biopsy Laparoscopic Forceps Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Biopsy Laparoscopic Forceps Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Biopsy Laparoscopic Forceps Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Biopsy Laparoscopic Forceps Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Biopsy Laparoscopic Forceps Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Biopsy Laparoscopic Forceps Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Biopsy Laparoscopic Forceps Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Biopsy Laparoscopic Forceps Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Biopsy Laparoscopic Forceps Market Competition by Key Manufacturers

9.1. Global Biopsy Laparoscopic Forceps Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Biopsy Laparoscopic Forceps: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. МНПО Эндомедиум

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Hangzhou Kangji Medical Instrument

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Unimicro

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Dewimed

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. AIIM

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. NovaProbe

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Biopsy Laparoscopic Forceps Market

Figure 4: Global Biopsy Laparoscopic Forceps Market: Drivers

Figure 5: Global Biopsy Laparoscopic Forceps Market: Challenges

Figure 6: Global Biopsy Laparoscopic Forceps Market: Trends

Figure 7: Global Biopsy Laparoscopic Forceps Market: Opportunity

Figure 8: Global Biopsy Laparoscopic Forceps Market: Restraint

Figure 9: Global Biopsy Laparoscopic Forceps Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Biopsy Laparoscopic Forceps Market Value (USD Million) By Region

Figure 19: Global Biopsy Laparoscopic Forceps Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Biopsy Laparoscopic Forceps Market Value (USD Million) By Region

Figure 27: Global Biopsy Laparoscopic Forceps Market Share (%) By: Regions (2032)

Figure 28: Global Biopsy Laparoscopic Forceps Market Volume (K) By Region

Figure 29: Global Biopsy Laparoscopic Forceps Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Biopsy Laparoscopic Forceps Market Value (USD Million) By Region

Figure 37: Global Biopsy Laparoscopic Forceps Market Share (%) By: Regions (2032)

Figure 38: Global Biopsy Laparoscopic Forceps Market Volume (K) By Region

Figure 39: Global Biopsy Laparoscopic Forceps Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

107 items

Table 1: Market Segmentation Analysis

Table 2: Global Biopsy Laparoscopic Forceps Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Biopsy Laparoscopic Forceps Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Biopsy Laparoscopic Forceps Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Biopsy Laparoscopic Forceps Market Value (USD Million) By Region

Table 14: Global Biopsy Laparoscopic Forceps Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Biopsy Laparoscopic Forceps Market Volume (K) By Region

Table 31: Global Biopsy Laparoscopic Forceps Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Biopsy Laparoscopic Forceps Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Biopsy Laparoscopic Forceps Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Biopsy Laparoscopic Forceps Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: МНПО Эндомедиум Basic Information And Sales Area

Table 52: МНПО Эндомедиум. Products Portfolio

Table 53: Hangzhou Kangji Medical Instrument Basic Information And Sales Area

Table 54: Hangzhou Kangji Medical Instrument. Products Portfolio

Table 55: Unimicro Basic Information And Sales Area

Table 56: Unimicro. Products Portfolio

Table 57: Dewimed Basic Information And Sales Area

Table 58: Dewimed. Products Portfolio

Table 59: AIIM Basic Information And Sales Area

Table 60: AIIM. Products Portfolio

Table 61: NovaProbe Basic Information And Sales Area

Table 62: NovaProbe. Products Portfolio

Table 63: Global Market Value (USD Million) (2025-2032) By Application

Table 64: Global Market Share (%) By Application (2032)

Table 65: Global Market Value (USD Million) (2025-2032) By Types

Table 66: Global Market Share (%) By Types (2032)

Table 67: Global Market Volume (K) (2025-2032) By Application

Table 68: Global Market Share (%) By Application (2032)

Table 69: Global Market Volume (K) (2025-2032) By Types

Table 70: Global Market Share (%) By Types (2032)

Table 71: Global Biopsy Laparoscopic Forceps Market Value (USD Million) By Region

Table 72: Global Biopsy Laparoscopic Forceps Market Share (%) By Region (2025-2032)

Table 73: North America Market Value (USD Million) (2025-2032) By Country

Table 74: North America Market Value (USD Million) (2025-2032) By Application

Table 75: North America Market Value (USD Million) (2025-2032) By Types

Table 76: Europe Market Value (USD Million) (2025-2032) By Country

Table 77: Europe Market Value (USD Million) (2025-2032) By Application

Table 78: Europe Market Value (USD Million) (2025-2032) By Types

Table 79: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 80: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 81: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 82: South America Market Value (USD Million) (2025-2032) By Country

Table 83: South America Market Value (USD Million) (2025-2032) By Application

Table 84: South America Market Value (USD Million) (2025-2032) By Types

Table 85: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 86: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 87: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 88: Global Biopsy Laparoscopic Forceps Market Volume (K) By Region

Table 89: Global Biopsy Laparoscopic Forceps Market Share (%) By Region (2025-2032)

Table 90: North America Market Volume (K) (2025-2032) By Country

Table 91: North America Market Volume (K) (2025-2032) By Application

Table 92: North America Market Volume (K) (2025-2032) By Types

Table 93: Europe Market Volume (K) (2025-2032) By Country

Table 94: Europe Market Volume (K) (2025-2032) By Application

Table 95: Europe Market Volume (K) (2025-2032) By Types

Table 96: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 97: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 98: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 99: South America Market Volume (K) (2025-2032) By Country

Table 100: South America Market Volume (K) (2025-2032) By Application

Table 101: South America Market Volume (K) (2025-2032) By Types

Table 102: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 103: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 104: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 105: Research Programs/Design For This Report

Table 106: Key Data Information From Secondary Sources

Table 107: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Biopsy Laparoscopic Forceps Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	4.50 billion
Revenue forecast in 2033	11.38 billion
Growth rate	CAGR of 12.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	МНПО Эндомедиум; Hangzhou Kangji Medical Instrument; Unimicro; Dewimed; AIIM; NovaProbe
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options